Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Philogen S.p.A.
Sponsor:
Information provided by (Responsible Party):
Philogen S.p.A.
ClinicalTrials.gov Identifier:
NCT01134250
First received: May 25, 2010
Last updated: October 20, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)